SEC 13F Intelligence

XTL BIOPHARMACEUTICALS LTD

CUSIP 98386D307

Xtl Biopharmaceuticals Ltd has 6 institutional holders in Filings Flow’s 13F database, together reporting 329.7K shares worth $190,883 as of Q4 2025. The largest reported holders are Noked Israel Ltd, Citadel Advisors LLC, and Rhumbline Advisers.

Institutional Holders
6
Q4 2025
Reported Value
$190,883
Ticker
unmapped
private placement or foreign
Quarters Tracked
28

Ownership Trend

Institutional holders
Q1 ’19: 4Q1 ’19Q2 ’19: 4Q3 ’19: 5Q4 ’19: 4Q1 ’20: 3Q1 ’20Q2 ’20: 3Q3 ’20: 4Q4 ’20: 4Q1 ’21: 6Q1 ’21Q2 ’21: 5Q3 ’21: 6Q4 ’21: 6Q1 ’22: 4Q1 ’22Q2 ’22: 3Q3 ’22: 3Q4 ’22: 3Q1 ’23: 2Q1 ’23Q2 ’23: 3Q3 ’23: 4Q4 ’23: 5Q1 ’24: 5Q1 ’24Q2 ’24: 4Q3 ’24: 3Q4 ’24: 3Q1 ’25: 4Q1 ’25Q2 ’25: 5Q3 ’25: 4Q4 ’25: 6filingsflow.com
Total reported value
Q1 ’19: $953,000Q1 ’19Q2 ’19: $803,000Q3 ’19: $603,000Q4 ’19: $546,000Q1 ’20: $468,000Q1 ’20Q2 ’20: $632,000Q3 ’20: $758,000Q4 ’20: $1MQ1 ’21: $2MQ1 ’21Q2 ’21: $2MQ3 ’21: $2MQ4 ’21: $1MQ1 ’22: $944,000Q1 ’22Q2 ’22: $604,000Q3 ’22: $442,000Q4 ’22: $241,363Q1 ’23: $261,000Q1 ’23Q2 ’23: $199,200Q3 ’23: $179,377Q4 ’23: $201,561Q1 ’24: $617,687Q1 ’24Q2 ’24: $532,813Q3 ’24: $492,774Q4 ’24: $425,564Q1 ’25: $282,844Q1 ’25Q2 ’25: $261,097Q3 ’25: $265,800Q4 ’25: $190,883filingsflow.com

Holders

··Mixed quarters
Export to Excel
Manager% of PortfolioValueSharesQuarter
Noked Israel Ltd$677M AUM0.02%$115,000198.9KQ4 2025
CITADEL ADVISORS LLC$618.5B AUM0.00%$44,00275.9KQ4 2025
RHUMBLINE ADVISERS$116.9B AUM0.00%$17,46030.1KQ4 2025
GAMMA Investing LLC$2.7B AUM0.00%$7,47412.9KQ4 2025
XTX Topco Ltd$5.8B AUM0.00%$5,93810.2KQ4 2025
MORGAN STANLEY$1.66T AUM0.00%$1,0091.7KQ4 2025
UBS Group AG$666.3B AUM0.00%$893763Q3 2025OLDER
CONCOURSE FINANCIAL GROUP SECURITIES, INC.$0 AUM—$00Q2 2025OLDER

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.